Poseida Therapeutics所有資訊

Poseida Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(4.97%)

06/07 13:33 (美東)

Poseida Therapeutics | 10-Q：季度報表

05/14 16:20 (美東)

Poseida Therapeutics | 8-K：Poseida Therapeutics提供2024年第一季度的最新情況和財務業績

05/14 16:10 (美東)

Poseida Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Novartis Pharma AG(0%),Novartis AG(0%)

05/08 16:06 (美東)

Poseida Therapeutics | EFFECT：其他

05/06 06:13 (美東)

Poseida Therapeutics | CORRESP：信函

05/01 22:22 (美東)

Poseida Therapeutics | 8-K：重大事件

05/01 09:09 (美東)

Poseida Therapeutics | ARS：年度報告

04/25 16:18 (美東)

Poseida Therapeutics | DEFA14A：其他

04/25 16:14 (美東)

Poseida Therapeutics | DEF 14A：股東委託書決議

04/25 16:12 (美東)

Poseida Therapeutics | 8-K：重大事件

04/17 09:19 (美東)

Poseida Therapeutics | UPLOAD：其他

04/11 22:16 (美東)

Poseida Therapeutics | S-3：特定交易註冊聲明

04/08 17:05 (美東)

Poseida Therapeutics | 8-K：重大事件

04/08 16:35 (美東)

Poseida Therapeutics | 4：持股變動聲明-高管 Rizvi Syed Ali-aamir

04/03 16:09 (美東)

Poseida Therapeutics | 3：首次持股聲明-高管 Rizvi Syed Ali-aamir

04/03 16:04 (美東)

Poseida Therapeutics | 10-K：年度報表

03/07 22:16 (美東)

Poseida Therapeutics | 8-K：Poseida Therapeutics提供2023年第四季度和全年的最新情況和財務業績

03/07 16:13 (美東)

Poseida Therapeutics | 4：持股變動聲明-高管 Mylet Johanna

03/04 17:41 (美東)

Poseida Therapeutics | 4：持股變動聲明-高管 LEONHARDT HARRY J

03/04 17:25 (美東)